Still, better than most biotechs navigating this multi-year black swan, even setting a new monthly revenue mark. I’ll be surprised if growth doesn’t accelerate out of the back end of the nightmare environment of the last 16 m9nths.
Ann: FY21 BTM Revenue Results, page-131
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
0.120(5.11%) |
Mkt cap ! $1.706B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.52 | $2.38 | $6.169M | 2.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3613 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 38844 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |